JM Financial sees 26% upside in Viyash Scientific, citing patent expiries, integration and R&D moat; read why it set a ₹338 ...
Old drives, mismatched and forgotten, finally earned their keep.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results